Cell & Gene Therapy
Biosafety
How Long Should Eyes Be Flushed After Exposure?
Blog Posts
Biosafety
Best Practices for Protecting Non-Participants in Human Gene Transfer Clinical Trials
Blog Posts
Cell & Gene Therapy
Why Biotech Sponsors Need Outside Support: IRB, IBC, DMCs and EACs
Whitepapers
Cell & Gene Therapy
Is special safety equipment required for IBC approval?
Blog Posts
Cell & Gene Therapy
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians
Whitepapers
Cell & Gene Therapy
Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Blog Posts
Cell & Gene Therapy
WCG IRB’s Response to COVID-19 in 2020: Supporting the Clinical Trial Industry When It Needed It the Most
Case Studies
Cell & Gene Therapy
[Video] Institutional Biosafety Committee Review: Strategies to Secure Rapid IBC Approval for Human Gene Transfer Trials
Videos
Cell & Gene Therapy
Four Key Elements You Need to Know About the Role of IBCs in Gene Therapy Trials
Blog Posts
Cell & Gene Therapy